Result Summary for ARI30015

Result Summary
Protocol ID: ARI30015
Clinical Study ID: ARIF 4010
Official Title: Multicentre, randomized, placebo-controlled, double-blind, parallel-group, phase IIIB clinical trial evaluating the efficacy of dutasteride in the prevention of bleeding related to prostate transurethral resection in subjects presenting with BPH.
Phase: Phase 3
Study Indications or Diseases:
  • Prostatic Hyperplasia
Generic Name: dutasteride
Trade/Product Name: avodart;avodart
Approved Drug Label: http://www.gsk.com/products/prescription-medicines/index.htm
Results Summary: Click here to download result summary. Click here to download result summary.
Citations: